Maria Palasis - President & CEO, Director at Lyra Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
LYRA on Nasdaq
All Insider Reports
All Insider Reports

Maria Palasis - trading volume in the past year for Lyra Therapeutics, Inc.

Holdings reported by Maria Palasis for Lyra Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,096,733 $3,689,409 $3.36 06 Jan 2026 Direct
Employee Stock Option (right to buy) 0 01 Oct 2025 Direct Common Stock

Transactions reported by Maria Palasis for Lyra Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.